Background-Microsomal prostaglandin E 2 synthase-1 (mPGES-1), encoded by the Ptges gene, catalyzes prostaglandin E 2 biosynthesis and is expressed by leukocytes, cardiac myocytes, and cardiac fibroblasts. Ptges Ϫ/Ϫ mice develop more left ventricle (LV) dilation, worse LV contractile function, and higher LV end-diastolic pressure than Ptges ϩ/ϩ mice after myocardial infarction. In this study, we define the role of mPGES-1 in bone marrow-derived leukocytes in the recovery of LV function after coronary ligation. Methods and Results-Cardiac structure and function in Ptges ϩ/ϩ mice with Ptges ϩ/ϩ bone marrow (BM ϩ/ϩ ) and
COX-2), and terminal prostaglandin synthase enzymes, participate in the regulation of the inflammatory response after MI. Prostaglandin E 2 (PGE 2 ) is the principal prostaglandin generated by cardiac myocytes. 4 The terminal step in PGE 2 biosynthesis may be catalyzed by the constitutively expressed enzymes cytosolic or microsomal PGE 2 synthase-2 (cPGES and mPGES-2, respectively), 5 or by mPGES-1, 6 an inducible enzyme. mPGES-1 is encoded by the Ptges gene and can be expressed by leukocytes, 7 cardiac fibroblasts, 8 and cardiac myocytes. 9 Inhibition of the PGE 2 receptor EP4 attenuates cardiomyocyte hypertrophy in vitro, 10 and deletion of EP4 exacerbates myocardial ischemia/reperfusion injury in vivo. 11 In addition, Ptges Ϫ/Ϫ mice develop more LV dilation, worse LV contractile function, and higher LV end-diastolic pressure than Ptges ϩ/ϩ mice after MI. 12 Collectively, these observations suggest a beneficial role for mPGES-1-mediated PGE 2 biosynthesis in postinfarction LV remodeling. The cellular source of mPGES-1 in the heart after MI has not been identified. In this study, we show that deletion of mPGES-1 in bone marrow-derived leukocytes results in a more intense inflammatory response, pathological LV remodeling, and increased mortality after acute MI in vivo.
Methods
Reagents were from Sigma Chemical Co (St. Louis, MO) unless otherwise stated. Construction of the mPGES-1-deficient mouse line (Ptges Ϫ/Ϫ , DBA/1lacJ background), 13 real-time quantitative polymerase chain reaction studies, 2-dimensional echocardiography, invasive hemodynamic assessment of LV function, morphometric assessment of hearts that were perfusion fixed at an intraventricular pressure of 20 mm Hg in situ, liquid chromatography-tandem mass spectrometry-based evaluation of prostanoid levels in cardiac tissue, immunoblotting, and lectin and Picrosirius Red staining were performed exactly as described previously. 9, 12, 14 Housing and experimental procedures were approved by the Animal Care Committee of the University Health Network and were in accordance with the Guide for the Care and Use of Laboratory Animals research statutes, Ontario (1980) .
MI Model
Mice were sedated with ketamine (50 mg/kg) and xylazine (5 mg/kg), intubated, ventilated, and maintained with 2% isoflurane. Through a left thoracotomy, the left coronary artery was ligated 1 to 2 mm below the border of the left atrial appendage. Ischemia was confirmed by the appearance of hypokinesis and pallor distal to the occlusion and by ST elevation on ECG. 12 
Multiple Epitope Ligand Cartography
Multiple epitope ligand cartography was performed as described previously. 15 Briefly, a slide with a cardiac section was placed on the stage of an inverted wide-field fluorescence microscope (Leica DM IRE2). By an automated process, tissue slices were incubated for 15 minutes with a fluorescence-labeled antibody and rinsed with wash solution, and fluorescence signals were imaged. A bleaching step was then performed to delete the fluorescence signal before addition of the next antibody. Postbleaching images were recorded and subtracted from the following fluorescence image.
Bone marrow transplantation and the generation of chimeric mice, isolation and coculture of cardiac fibroblasts and bone marrowderived mononuclear cells/macrophages, antisera for immunohistochemistry, primer sequences for real-time reverse-transcription polymerase chain reaction analysis, and the statistical analysis appear in the online-only Data Supplement.
The authors had full access to and take full responsibility for the integrity of the data. All authors have read and agree to the manuscript as written.
Results

LV Dilation, Impaired LV Systolic and Diastolic Function, and Increased Mortality After MI in Mice That Lack mPGES-1 in Bone Marrow-Derived Cells
To define the role of mPGES-1 in myeloid cells in the pathophysiology of acute MI, we generated chimeric Ptges ϩ/ϩ mice with Ptges ϩ/ϩ bone marrow (BM ϩ/ϩ ) and Ptges ϩ/ϩ mice with Ptges Ϫ/Ϫ bone marrow (BM Ϫ/Ϫ ) and evaluated cardiac dimensions and function in these mice before (tϭ0) and up to 28 days after coronary ligation. Bone marrow cells in chimeras were predominantly from donor mice before and up to 28 days after MI ( Figure 1A ). After MI, survival was significantly worse in BM Ϫ/Ϫ than in BM ϩ/ϩ mice, and most deaths occurred between 19 and 28 days after infarction ( Figure 1B ). At 28 days post-MI, LV volume (Figures 1C and 1D) and diameter (Table) , measured after hyperkalemic arrest and constant-pressure in situ perfusion fixation, 12 were 43% and 30% greater in BM Ϫ/Ϫ than BM ϩ/ϩ mice, respectively. Conversely, the volume of infarcted myocardium ( Figures 1C and 1E ) and the thickness of the interventricular septum (Table) were similar in BM ϩ/ϩ and BM Ϫ/Ϫ mice 28 days after MI.
Next, we assessed LV dimensions and LV function in BM ϩ/ϩ and BM Ϫ/Ϫ chimeras in vivo by 2-dimensional echocardiography and invasive hemodynamic monitoring. The decrease in LV fractional shortening in BM ϩ/ϩ and BM Ϫ/Ϫ mice 7 days after coronary ligation was comparable and indicated significant MI in both groups of mice ( Figure  1F ). Fractional shortening and ϩdP/dt ( Figure 1G ), indexes of LV systolic function, and ϪdP/dt and (Figures 1H and 1I), indicators of the diastolic properties of the LV, were all significantly worse in BM Ϫ/Ϫ than BM ϩ/ϩ mice 28 days after MI. BM Ϫ/Ϫ mice also had higher LV diameter and LV volume at end systole but not end diastole, a lower stroke volume ( Table) , and higher LV end-diastolic pressure ( Figure  1J ) than BM ϩ/ϩ mice 28 days after MI. Collectively, these findings established accelerated deterioration of cardiac function in BM Ϫ/Ϫ compared with BM ϩ/ϩ chimeras after MI. Although stroke volume and cardiac output in BM ϩ/ϩ mice recovered by 28 days after MI to baseline levels, possibly reflecting compensatory remodeling (Table) , fractional shortening, stroke volume, and cardiac output remained below baseline levels in BM Ϫ/Ϫ mice ( Figure 1F ; Table) 28 days after MI.
The surface area of cardiac myocytes, a measure of cardiomyocyte hypertrophy, 12 increased more in BM Ϫ/Ϫ than BM ϩ/ϩ mice 28 days after MI ( Figures 1L and 1M ). Despite differences in cardiomyocyte hypertrophy and cardiac function, respiratory rate ( Table) and the pulmonary wet-to-dry weight ratio ( Figure 1K ) were similar in BM ϩ/ϩ and BM Ϫ/Ϫ mice after MI. In addition, there was no difference in collagen remodeling ( Figures 1N and 1O ), matrix metalloproteinase-2 or -9 mRNA expression (online-only Data Supplement Figure  I Taken together, these results provide direct evidence that loss of mPGES-1 in bone marrow-derived myeloid cells leads to impaired LV systolic and diastolic function and is associated with increased mortality after coronary occlusion. Compared with BM ϩ/ϩ mice, BM Ϫ/Ϫ mice that survived 28 days after MI had impending LV failure, manifested as LV dilation and an increase in LV end-diastolic pressure, but did not develop overt pulmonary edema. Because a lack of mPGES-1 in bone marrowderived myeloid cells has no effect on infarct volume after coronary ligation but increases LV volume, LV end-diastolic pressure, and cardiomyocyte hypertrophy, these data are consistent with the notion that lack of mPGES-1 in bone marrow-derived myeloid cells impairs LV remodeling 28 days after MI in these mice. 
Lack of mPGES-1 in Bone Marrow-Derived Cells Increases the Inflammatory Response to MI
MI stimulates an inflammatory response that is characterized by an increase in cytokine and chemokine gene expression and leukocyte recruitment to the heart. An appropriately regulated inflammatory response is necessary for physiological LV remodeling and healing after MI. 16, 17 To assess the role of mPGES-1 in bone marrow-derived cells in the inflammatory response to MI, we studied the expression of a panel of genes that regulate inflammation in BM ϩ/ϩ and BM Ϫ/Ϫ mice. Levels of interleukin-1␤ (IL-1␤), IL-1␤ receptor antagonist, and tumor necrosis factor-␣ mRNA in the infarct region increased significantly after MI in both chimeras, and the expression of these genes was higher in BM Ϫ/Ϫ than BM ϩ/ϩ mice 7 days after MI (Figures 2A through 2C ). Levels of monocyte chemotactic protein-1 and macrophage inflammatory protein-2 mRNA in the infarct also increased after MI in both chimeras but were not different between BM Ϫ/Ϫ and BM ϩ/ϩ mice ( Figures 2D and 2E) . Changes in keratinocytederived chemokine mRNA expression in the infarct were not identified after MI in these mice ( Figure 2F ). There was no difference in the expression of IL-1␤, IL-1␤ receptor antagonist, tumor necrosis factor-␣, monocyte chemotactic protein-1, macrophage inflammatory protein-2, or keratinocyte-derived chemokine in the LV remote from the infarct between BM Ϫ/Ϫ and BM ϩ/ϩ mice (online-only Data Supplement Figure IV ).
Next, we measured tissue levels of myeloperoxidase (MPO), an enzyme contained in the granules of neutrophils and monocytes that is released on leukocyte activation and that has been used as a marker of leukocyte infiltration into the heart after MI. 16, 17 Levels of MPO were significantly higher in the infarct of BM Ϫ/Ϫ than BM ϩ/ϩ mice 7 but not 28 days after MI ( Figures 2G and 2H ). Conversely, there was no difference in MPO protein levels in the LV remote from the infarct between BM Ϫ/Ϫ and BM ϩ/ϩ mice after coronary ligation (online-only Data Supplement Figure IV) .
To independently confirm the observation that leukocyte infiltration was augmented in the infarct of mice that lacked mPGES-1 in bone marrow-derived cells, we performed immunohistochemical analysis of CD45, which is expressed on leukocytes, and MPO before and 7 and 28 days after MI. Consistent with the results of the MPO immunoblotting studies, we found that levels of both CD45 (Figures 2I and 2J) and MPO (online-only Data Supplement Figure V) were significantly higher in the infarct of BM Ϫ/Ϫ than BM ϩ/ϩ mice 7 but not 28 days after MI. Taken together, these results demonstrate that lack of mPGES-1 in bone marrow-derived cells increases the inflammatory response to MI.
Increased LV COX-1 Expression and Prostaglandin Levels in BM Ϫ/Ϫ Mice After MI
Targeted deletion of mPGES-1 leads to alterations in the biosynthesis of multiple prostaglandins in macrophages, 7 and macrophages are the most prominent inflammatory cells in the infarct zone 7 days after MI. 18 To explore whether changes in prostaglandin concentrations may explain the differences in leukocyte recruitment between BM Ϫ/Ϫ and BM ϩ/ϩ mice after coronary ligation, we measured levels of prostaglandins in the infarct zone and in the viable portion of the LV adjacent to the infarct by liquid chromatographytandem mass spectrometry. Concentrations of PGE 2 , thromboxane B 2 (TxB 2 , a stable TxA 2 metabolite), PGF 2␣ , 6 keto-PGF 1␣ (a stable PGI 2 metabolite), and total prostaglandins were significantly higher in the infarct of BM Ϫ/Ϫ than
Table. Cardiac Dimensions and Function Before and 7 and 28 Days After Left Coronary Artery Ligation
Days After Coronary Ligation BM ϩ/ϩ mice 7 but not 28 days after MI ( Figures 3A through  3F) . Similarly, PGE 2 , PGD 2 , TxB 2 , 6 keto-PGF 1␣ , and total prostaglandin levels were higher in the viable myocardium adjacent to the infarct in BM Ϫ/Ϫ than in BM ϩ/ϩ mice 7 but not 28 days after coronary ligation (online-only Data Supplement Figure VI , A through F).
To identify the molecular mechanisms that resulted in increased prostaglandin levels in the infarct and LV of BM Ϫ/Ϫ compared with BM ϩ/ϩ mice, we assessed prostaglandin biosynthetic enzyme gene expression in these chimeras after MI. Our studies focused on COX-1 and COX-2 because these enzymes catalyze the formation of PGH 2 , the precursor of all prostaglandins, and we noted an increase in the level of multiple prostaglandins after MI (Figure 3 ; online-only Data Supplement Figure VI) . mRNA levels of COX-1, a constitutively expressed enzyme, and COX-2, an inducible enzyme, were higher in the infarct zone of BM Ϫ/Ϫ than BM ϩ/ϩ mice 7 and 28 days after MI ( Figures 3G and 3H) . The level of mPGES-1 mRNA in the infarct was also higher in BM Ϫ/Ϫ than BM ϩ/ϩ mice 7 but not 28 days after MI ( Figure 3I ). The source of the increase in mPGES-1 mRNA in the infarct of BM Ϫ/Ϫ mice must have been resident cardiac cells, because bone marrow-derived cells recruited to the heart in these mice were from Ptges Ϫ/Ϫ mice ( Figure 1A) , which do not express mPGES-1 mRNA. There was no change in mPGES-2 mRNA levels in either chimera 7 or 28 days after coronary ligation (data not shown).
COX-1 protein levels in the infarct were higher in BM Ϫ/Ϫ than in BM ϩ/ϩ mice 7 but not 28 days after MI ( Figures 3J and  3K) . Conversely, the level of COX-2 protein in the infarct was higher in both BM ϩ/ϩ and BM Ϫ/Ϫ mice 7 and 28 days after coronary ligation than at baseline, but there was no difference in the level of COX-2 protein in the infarct between these chimeras after MI ( Figures 3J and 3L ). No change in the level of mPGES-1 ( Figure 3M ) or mPGES-2 protein (not shown) in the infarct of BM ϩ/ϩ or BM Ϫ/Ϫ mice was identified by immunoblot analysis. These data demonstrate that the loss of mPGES-1 in bone marrow-derived myeloid cells led to a compensatory increase in COX-1 protein expression in the infarcted myocardium after coronary ligation in BM Ϫ/Ϫ mice.
Next, we performed immunohistochemical analysis of cardiac sections to localize COX-1, COX-2, and mPGES-1 Figure VI , A through F) were identified between BM Ϫ/Ϫ and BM ϩ/ϩ mice. Seven days after MI, COX-1 protein was present in the infarct, with apparently more intense staining in BM Ϫ/Ϫ than BM ϩ/ϩ mice ( Figures 4A and 4B) , consistent with the immunoblot analysis ( Figures 3J and 3K ). Scant cells stained positively for COX-2 protein 7 days after MI ( Figures  4A and 4B ). Inflammatory cells in the infarct zone expressed mPGES-1 protein in BM ϩ/ϩ mice ( Figure 4A ), as previously observed in Ptges ϩ/ϩ mice after MI. 12 In addition, elongated cells in the infarct zone of BM Ϫ/Ϫ mice also expressed mPGES-1 protein ( Figure 4B ). The identity of these cells is unknown, but they could not have been bone marrowderived leukocytes, because all bone marrow-derived cells in BM Ϫ/Ϫ mice lacked the ability to express mPGES-1 ( Figure  1A) . Therefore, the cells that expressed mPGES-1 protein in BM Ϫ/Ϫ mice 7 days after MI must have been resident cardiac cells.
In contrast to the changes in prostaglandin biosynthetic enzyme gene expression in the infarcted myocardium (Figures 3G through 3I) , there was no difference in COX-1, COX-2, mPGES-1, mPGES-2, or cPGES mRNA levels in the viable LV adjacent to the infarct in BM ϩ/ϩ and BM Ϫ/Ϫ mice after MI (online-only Data Supplement Figure VII , A through E).
Cardiac Fibroblasts Express COX-1, COX-2, and mPGES-1 Protein in Infarcted Myocardium
To identify the resident cardiac cells that expressed mPGES-1 ( Figure 4B ) and COX-1 and COX-2 protein in the infarct of these chimeras, we performed multiple epitope ligand cartography-based evaluation of the LV of Ptges ϩ/ϩ and Ptges Ϫ/Ϫ mice and in BM ϩ/ϩ and BM Ϫ/Ϫ chimeras 7 days after MI (the time when differences in prostaglandin levels between BM ϩ/ϩ and BM Ϫ/Ϫ chimeras were noted; Figures 3A through 3F and online-only Data Supplement Figure VI , A through F). Multiple epitope ligand cartography enables sequential immunofluorescence-based visualization of multiple proteins in a tissue sample and can be used to identify the cell type that an individual protein is expressed in, and to determine which proteins colocalize in individual cells. 19 In Ptges ϩ/ϩ mice, mPGES-1 localized with COX-1 and COX-2 in cardiac fibroblasts but was not expressed in cardiomyocytes after MI (online-only Data Supplement Figure VIII) . As expected, there was no mPGES-1 staining in the LV of Ptges Ϫ/Ϫ mice, which served as a negative control, after MI (online-only Data Supplement Figure IX) . In BM ϩ/ϩ chimeras, mPGES-1 colocalized with COX-1 and COX-2 in cardiac fibroblasts ( Figures 4C through 4F ; online-only Data Supplement Figure X) . Because these cells also express PLA 2 enzymes, 20 cardiac fibroblasts have all of the enzymatic machinery necessary to catalyze PGE 2 biosynthesis. In con- trast, cardiomyocytes did not express mPGES-1 in BM ϩ/ϩ mice ( Figure 4G ) after MI. In BM Ϫ/Ϫ chimeras, mPGES-1 also colocalized with COX-1 and COX-2 in cardiac fibroblasts but did not colocalize with cardiomyocytes ( Figures 4C  through 4G ; online-only Data Supplement Figure X) . Taken together, these findings support the conclusion that the cells that stained positively for mPGES-1 on immunohistochemical analysis of BM Ϫ/Ϫ mice 7 days after MI ( Figure 4B ) were most likely cardiac fibroblasts.
Higher PGE 2 Production by Cardiac Fibroblasts Than Mononuclear Cells/Macrophages In Vitro
The relative capacity of cardiac fibroblasts and macrophages, the most prevalent inflammatory cell recruited to the infarct zone 7 days after MI, 18 to generate PGE 2 in vitro was evaluated next. Treatment with IL-1␤ increased PGE 2 production in vitro by bone marrow-derived mononuclear cells/ macrophages and by cardiac fibroblasts from Ptges ϩ/ϩ mice ( Figure 5A) . On a per cell basis, cardiac fibroblasts produced 8.8-fold more PGE 2 than bone marrow-derived mononuclear cells/macrophages after exposure to IL-1␤ in vitro ( Figure  5A ). Although the protocol used generated a cellular population that was highly enriched in cardiac fibroblasts (online-only Data Supplement Methods), it is possible that other cells in this preparation also produced PGE 2 in response to IL-1␤.
Because PGH 2 generated by macrophages recruited to the infarct may diffuse out of these cells and be metabolized to PGE 2 by mPGES-1 in adjacent cardiac fibroblasts, we evaluated the effect of coculturing cardiac fibroblasts from Ptges ϩ/ϩ mice with mononuclear cells/macrophages from Ptges ϩ/ϩ or Ptges Ϫ/Ϫ mice in vitro. There is no difference in the level of PGE 2 in the supernatant of Ptges ϩ/ϩ cardiac fibroblasts after coculture with mononuclear cells/macrophages from either Ptges ϩ/ϩ or Ptges Ϫ/Ϫ mice and treatment with vehicle or IL-1␤ in vitro ( Figure 5B ).
Discussion
To the best of our knowledge, this is the first study to demonstrate that a prostaglandin biosynthetic enzyme in bone marrow-derived leukocytes, in this case mPGES-1, can regulate leukocyte infiltration, cardiomyocyte hypertrophy, LV systolic and diastolic function, and survival after MI. These findings are physiologically important because they suggest that mPGES-1 in bone marrow-derived leukocytes prevents pathological LV remodeling in a clinically relevant model of coronary artery occlusion in vivo. The molecular mechanism that leads to pathological LV remodeling in BM Ϫ/Ϫ compared with BM ϩ/ϩ mice may be related to the observation that levels of PGE 2 and other prostaglandins are higher in the viable LV adjacent to the infarct in BM Ϫ/Ϫ mice than in BM ϩ/ϩ mice. Importantly, there was no difference in the expression of prostaglandin biosynthetic enzymes in the viable LV adjacent to the infarct between these chimeras, so the differences in prostaglandin levels in the viable LV adjacent to the infarct cannot be explained by local differences in prostaglandin production. On the basis of these observations, we propose a novel model in which prostaglandins or their precursor PGH 2 , generated in the infarct, diffuse into the surrounding viable LV, interact with prostaglandin receptors on cardiomyocytes, 4,10,21 and act as paracrine regulators of cardiomyocyte hypertrophy and LV remodeling in vivo.
The present in vivo data do not permit identification of the prostaglandin(s) that modulate cardiac myocyte hypertrophy and pathological LV remodeling in BM Ϫ/Ϫ mice after MI. That limitation notwithstanding, the independent observations that (1) PGE 2 stimulates cardiac myocyte hypertrophy in vitro, 4, 10, 22 (2) inhibition or deletion of the PGE 2 receptor EP4 attenuates cardiomyocyte hypertrophy in vitro 10 and in vivo, 21 respectively, (3) Ptges Ϫ/Ϫ mice have lower levels of PGE 2 and less cardiac myocyte hypertrophy than Ptges ϩ/ϩ mice after MI, 12 (4) Ptges Ϫ/Ϫ mice have an impaired cardiac hypertrophic response compared with Ptges ϩ/ϩ mice to angiotensin II infusion in vivo, 23 and (5) BM Ϫ/Ϫ mice have higher levels of PGE 2 and more cardiac myocyte hypertrophy than BM ϩ/ϩ mice (cf Figures 1 and 3 ) strongly suggest that PGE 2 directly regulates cardiac myocyte hypertrophy after MI in vivo.
Independent molecular mechanisms may account for the increased levels of PGE 2 and other prostaglandins in the LV of BM Ϫ/Ϫ mice 7 days after MI. For example, COX-1 catalyzes the biosynthesis of PGH 2 , the precursor of all prostaglandins, and COX-1 mRNA and protein expression is higher in the infarct of BM Ϫ/Ϫ than BM ϩ/ϩ mice. Although inflammatory responses are commonly associated with increased COX-2 expression, 24 induction of COX-1 has been observed during inflammatory responses and cellular differentiation. 25, 26 It is possible that IL-1␤ stimulates COX-1 expression in BM Ϫ/Ϫ mice after MI, because IL-1␤ can stimulate COX-1 expression in cultured fibroblasts under certain conditions, 27 and coronary ligation leads to higher IL-1␤ mRNA levels in the infarct of BM Ϫ/Ϫ than BM ϩ/ϩ mice (Figure 2A ). In addition, targeted deletion of COX-2 can lead to a compensatory increase in COX-1 expression in some biological systems, 28, 29 so it is possible that lack of COX-2-mPGES-1-catalyzed PGE 2 biosynthesis leads to a compensatory increase in COX-1 expression in BM Ϫ/Ϫ mice.
Because mPGES-2 and cPGES can also catalyze the terminal step in PGE 2 biosynthesis, the increase in PGE 2 levels in the heart of BM Ϫ/Ϫ mice could be catalyzed by COX-1-mPGES-2-or COX-1-cPGES-mediated pathways. Alternatively, cardiac fibroblasts, which express COX-1, COX-2, and mPGES-1 (Figure 4 ) and make Ϸ8.8-fold more PGE 2 on a per cell basis than mononuclear cells/macrophages in vitro after treatment with IL-1␤ (cf Figure 5A) , may be a direct source of PGE 2 production in the heart after MI. A third possibility is that in inflammatory leukocytes recruited to the heart of BM Ϫ/Ϫ chimeras after MI, PGH 2 catalyzed by COX-1 or COX-2 builds up in these cells, because it is not metabolized by mPGES-1. This excess PGH 2 may diffuse out of inflammatory leukocytes and be metabolized to PGE 2 by mPGES-1 in adjacent cardiac fibroblasts. Although transcellular prostaglandin metabolism has been observed in other biological systems 30 and could explain the increase in PGE 2 levels in the infarct of BM Ϫ/Ϫ compared with BM ϩ/ϩ mice after MI, our failure to observe differences in PGE 2 production when cardiac fibroblasts from Ptges ϩ/ϩ mice were cocultured with mononuclear cells/macrophages from Ptges ϩ/ϩ or Ptges Ϫ/Ϫ mice mitigates against this hypothesis. A limitation of the present study is that our in vivo and in vitro data do not permit us to clearly identify which specific molecular pathway(s) or cells regulate PGE 2 production in the LV after MI.
MI stimulates an inflammatory response that is characterized by the sequential recruitment of polymorphonuclear leukocytes, macrophages, and monocytes that are necessary to clear necrotic debris and to promote matrix deposition, granulation tissue formation, angiogenesis, and infarct healing. 18 In addition, leukocyte-mediated oxidation reactions play a critical role in LV remodeling after MI. 16 Perturbations in the inflammatory response are known to impair the recovery of LV function after infarction. 31, 32 The observation that lack of mPGES-1 in bone marrow-derived cells increases IL-1␤, IL-1␤ receptor antagonist, and tumor necrosis factor-␣ mRNA expression and leukocyte recruitment to the infarct (cf Figure 2 ) may explain the adverse LV remodeling that we observed in BM Ϫ/Ϫ compared with BM ϩ/ϩ mice after MI.
Inhibition of COX-2 leads to an imbalance of prothrombotic prostaglandins (increased TxA 2 ) and antithrombotic prostaglandins (decreased PGI 2 ) that is proposed to increase the risk of MI and stroke 33 and to increase mortality after MI. 34 Deletion of mPGES-1, downstream from COX-2 in the inducible PGE 2 biosynthetic cascade, decreases brain ischemia-reperfusion injury, 35 plaque burden in fat-fed Ptges -/low-density lipoprotein receptor-deficient (LDLR -/-) mice, 36 aortic aneurysm formation, 37 and DOCA-salt-and angiotensin II-induced hypertension, 38 as well as pain, fever, and inflammation in animal models of these diseases. 13, 39 Conversely, global deletion of mPGES-1 does not disturb the balance between prothrombotic and antithrombotic prostaglandin production in vivo. On the basis of these results, pharmacological inhibitors of mPGES-1 are proposed as an alternative to inhibition of COX-2 in the management of patients with atherosclerosis, pain, and inflammatory diseases. 40 The present results suggest that mPGES-1 in bone marrow-derived leukocytes negatively regulates the intensity of the inflammatory response to infarction and is necessary for physiological LV remodeling and recovery of LV contractile function after MI. Importantly, the effects of deletion of Ptges in bone marrow-derived leukocytes on cardiac physiology in mice may not be observed after administration of pharmacological inhibitors of the Ptges gene product mPGES-1 in animal models of MI, or in patients. For example, 50% of mice lacking COX-2 develop diffuse cardiac fibrosis, but this finding is not observed in patients taking selective COX-2 inhibitors, possibly because of incomplete pharmacological inhibition of COX-2 in vivo. In addition, inhibition of COX-2 is cardioprotective in mice 41 but results in adverse LV remodeling and LV rupture in a porcine MI model. 42 These observations underscore the need for caution in extrapolating our findings in mice to humans and identify the need to confirm these results in clinically relevant MI models in larger animals.
